Trademarkia Logo

Canada

C$
Trademark Search in Canada
SEMI-CIRCLE DESIGN

View On IC.GC.CA

SEMI-CIRCLE DESIGN
FORMALIZED

on 7 Sept 2022

Last Applicant/ Owned by

PFIZER IRELAND PHARMACEUTICALS

Operations Support GroupRingaskiddy, County Cork,

IE

Serial Number

2208132 filed on 7th Sept 2022

Correspondent Address

TORYS LLP

SUITE 300079 WELLINGTON ST. W.BOX 270, TD CENTRETORONTO

ONTARIO

CA

M5K1N2

SEMI-CIRCLE DESIGN

Trademark usage description

pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood, anxiety and cognitive disorders; pharmaceutical preparations for Read More

Vienna Information

25 . 12 . 1

Surfaces or backgrounds covered with rays or radiating linesSurfaces ou fonds rayonnés

26 . 1 . 1

CirclesCercles

26 . 1 . 3

One circle or ellipseUn cercle ou une ellipse

26 . 1 . 26

Circles or ellipses with cutout areasCercles ou ellipses avec des zones découpées

26 . 2 . 1

Segments of circles or ellipses (except 26.2.7)Segments de cercle ou d'ellipse (excepté 26.2.7)

26 . 2 . 26

Segments or sectors of circles or ellipses, semi-circles or semi-ellipses with cutout areasSegments ou secteurs de cercles ou ellipses, demi-cercles ou demi-ellipses avec des zones découpées

26 . 11 . 3

More than two lines or two bandsPlus de deux lignes ou de deux bandes

26 . 11 . 7

Vertical lines or bandsLignes ou bandes verticales

26 . 11 . 8

Horizontal lines or bandsLignes ou bandes horizontales

26 . 11 . 9

Oblique lines or bandsLignes ou bandes obliques

26 . 11 . 10

Straight lines or bandsLignes ou bandes droites

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood, anxiety and cognitive disorders; pharmaceutical preparations for the treatment of neurodegenerative, nerve, neuromuscular and brain diseases and disorders, namely muscular dystrophy; Pharmaceutical preparations for the treatment of bone growth disorders; Pharmaceutical preparations for the treatment of the central nervous system, namely brain diseases and central nervous system movement disorders; Pharmaceutical preparations for the treatment of cardiovascular, gastrointestinal, blood, and diseases and disorders; Pharmaceutical preparations for the treatment of auto-immune diseases and disorders, namely rheumatoid arthritis, systemic lupus, alopecia areata, and systemic sclerosis; Pharmaceutical preparations for the treatment of hypertension, menopause symptoms, obesity, stroke, arthritis, and pain; Pharmaceutical preparations for the treatment of cancer; Anti-infectives, anti-inflammatories, anti-viral agents, human vaccines; Pharmaceutical preparations for use in discouraging smoking habits; Pharmaceutical preparations for the treatment of kidney and liver disease and disorders; Pharmaceutical preparations for the treatment of diseases and disorders of the endocrine system, namely growth and thyroid disorders; Pharmaceutical preparations for the treatment of inflammatory diseases, namely inflammatory bowel diseases, inflammatory joint diseases, inflammatory connective tissue diseases, inflammatory muscle diseases and disorders; Pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely cachexia, diabetes, hypoglycemia, muscular dystrophy, obesity, sickle cell disease, non-alcoholic steatohepatitis (NASH) and anemia; Pharmaceutical preparations for the treatment of skin and dermatological diseases and conditions, namely eczema, atopic dermatitis, psoriasis, bacterial skin infections, and viral skin infections; Pharmaceutical preparations for the treatment of migraine

Classification kind code

11

Class [044]
Medical information services, namely, providing information related to pain, headache, facial pain, migraine and treatment of pain, headache, facial pain, and migraine

Classification kind code

11

Mark Details

Serial Number

2208132

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 80
on 22nd Nov 2023		Change of Title Registered
Submitted for opposition 48
on 8th Jun 2023		Agent Changed
Submitted for opposition 287
on 13th Oct 2022		Pre-Assessment Letter Sent
Submitted for opposition 67
on 7th Oct 2022		Agent Name Changed
Submitted for opposition 30
on 7th Sept 2022		Filed
Submitted for opposition 1
on 7th Sept 2022		Created
Submitted for opposition 31
on 7th Sept 2022		Formalized